John Muir Health logo
  • Patients
    About MyChart
    Locating Patients
    Medicare
    New Patients
    Payment & Insurance
    Physician Open Payments Notice
    Preparing for Surgery
    Pre-Register for a Visit
    Registration & Forms
    Request a Health Record
    Security Center
    Video Visits
    Why Choose Us
  • Services
    Addiction Medicine
    Behavioral Health
    Cancer
    Cardiovascular Services
    Digestive Health
    Emergency Services
    Lab Services
    Medical Imaging
    Neurosciences
    Orthopedics
    Pediatrics
    Physical Rehabilitation
    Pregnancy & New Parent
    Primary Care
    Urgent Care
    ALL SERVICES
  • Education
    Classes, Screenings & Support Groups
    Clinical Trials
    Conditions & Treatments
    Health & Wellness
  • For Providers
    Careers
    Clinical Research
    Family Medicine Residency Program
    John Muir Medical Group
    Medical Staff
    Nursing
    Pharmacy Residency Program
    Resources
    Training & Education
  • Giving
    Give Now
    The Foundation
    Donor Impact
    Gift Opportunities
    Ways to Give
    Contact Us
  • About
    Annual Reports
    Awards & Recognition
    Board of Directors
    Community Commitment
    Employers, Brokers, & Health Plans
    Executive Team
    Make a Gift
    Mission & Vision
    Partnerships
    Media Center
MyChart Login
  • Find a location
  • Find a doctor
  • Pay a bill
  • Find a job
✕

Latest information on COVID-19 >

Head and Neck Cancer Services

  1. Home
  2. Services
  3. Cancer
  4. What We Treat
  5. Head and Neck Cancer Services
What We Treat
  • Breast Health Services
  • Colon and Rectal Cancer Services
  • Esophageal Cancer Services
  • Gynecologic Cancer Services
  • Head and Neck Cancer Services
  • Lung Cancer Services
  • Skin and Melanoma Services
  • Urologic Cancer Services
  • Blood Cancer Services

Head and Neck Cancer Services

Head and neck masses (and cancers) can affect nasal passages, sinuses, mouth, throat, larynx (voice box), swallowing passages, salivary glands and thyroid gland. Skin cancers that develop on the scalp, face or neck also may be considered head and neck cancers.

Oropharyngeal cancer

Oropharyngeal cancer is a disease in which malignant cells form in the tissue of oropharynx. Oropharynx is a middle part of the throat which includes the base of the tongue, the tonsils, the soft palate, and the walls of the pharynx. Oropharyngeal cancers can be divided into two types, HPV-positive, which are related to human papillomavirus infection, and HPV-negative cancers, which are usually linked to alcohol or tobacco use.

Thyroid Cancer

Thyroid nodules are very common, and up to 60% of the population have thyroid nodules based on imaging studies such as ultrasound; however, more than 90% of those nodules are benign.

According to the American Cancer Society, 62,000 new patients will be diagnosed with thyroid cancer in 2016. Two out of three thyroid cancers are found in women, and it is the 5th most common type of cancer in women. During the past two decades there has been a steep rise in the incidence of well differentiated thyroid cancer that is in part due to earlier detection and increased imaging utilization, but the survival rate has remained unchanged. The majority of thyroid cancers that account for this increased incidence are smaller tumors that are less than 2 centimeters with indolent behavior — they rarely cause problems.

There are 4 major cell types of thyroid cancer: papillary, follicular, medullary, and anaplastic thyroid cancer. Well differentiated thyroid cancer accounts for more than 90% of the neoplasms of the thyroid gland. Papillary thyroid cancer is the most common type of well differentiated thyroid cancer. Thyroid cancer is more common in women and its incidence increases with age. Evidence suggests that family history of thyroid cancer, history of exposure to radiation, iodine deficiency and auto immune thyroiditis are associated with increased risk of thyroid cancer.

Evaluation of the thyroid gland usually includes clinical examination, laboratory values, and ultrasound imaging. Some patients may feel a mass in the neck or a nodule in the thyroid gland; sometimes they are found during a physical exam. Palpable nodules in the thyroid warrant evaluation by a thyroid specialist. Generally, nodules less than 1 cm should be observed without a need for biopsy. The majority of patients with thyroid cancer are asymptomatic and will have a normal thyroid blood test. If any suspicious nodule that meets the biopsy criteria is identified, an ultrasound guided fine needle aspiration biopsy may be considered. This is often done in during the office visit if feasible. The biopsy findings will be categorized based on Bethesda classification and may be reported as benign, malignant or suspicious, indeterminate, and non-diagnostic. Molecular genetic testing may offer additional information in indeterminate nodules.

The primary management of thyroid cancer is surgery when treatment is necessary. We now know that many smaller thyroid cancers of certain cell types can be treated with very limited surgery. If cancer is diagnosed, evaluation of the neck lymph nodes is usually done prior to surgical consideration. Extent of surgery will depend on multiple variables such as the presence of thyroid cancer in the lymph nodes. Additional treatment such as radioactive iodine may be indicated for a select group of patients with thyroid cancer. Surgical management of thyroid cancer is best done by surgeons with special interest in thyroid disease as high-volume surgeons are shown to have fewer complications. Your endocrinologist and thyroid surgeon will tailor specific treatment based on the extent of disease and your general health.

Patients with thyroid cancer will need periodic follow up examination by their physicians as the cancer can return many years after initial treatment in the neck. Patients who have undergone total thyroidectomy will need lifelong thyroid hormone replacement. Five-year overall survival for patients is excellent — with well differentiated thyroid cancer is above 95% for all stages combined and is near 100% in patients with early stage thyroid cancer.

Hi! I'm here to help answer your questions.
Chat
ABOUT
About Us
Board of Directors
Executive Team
Awards & Recognition
Partnerships
Community Commitment
Employers, Brokers & Health Plans

GET INVOLVED

Careers
Volunteer
NEWS & PRESS
Media Center
Annual Reports

GIVING

Make a Gift
Donor Bill of Rights
Foundation's Privacy Policy
CONTACT
Email Us
PRIVACY
Patient Privacy
Website Privacy
Terms of Use
Security Center
Follow Us

© John Muir Health All rights reserved.

John Muir Health is accredited by The Joint Commission. 

We use cookies to measure website traffic and personalize content for a better browsing experience. By using this website, you consent to our cookies. For more details, see our Website Privacy Policy.